DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/t3ptkq/nuclear) has announced the addition of the "Nuclear Medicine/Radiopharmaceuticals Global Market - Forecast to 2022" report to their offering.
The global nuclear medicine/radiopharmaceutical market is expected to reach 9,275.3 million by 2022. Nuclear medicinal market is mainly classified into type (diagnosis & therapeutics), application and end-users. The global nuclear medicine market by diagnosis is further divided into SPECT and PET while therapeutics market is segmented into alpha radiation therapy, beta radiation therapy and brachytherapy.
The nuclear medicine market end-users include medical, academic research laboratories and industries. The end-users by medical further segmented into hospitals and diagnostic centers.
The nuclear medicine/radiopharmaceutical market includes stable isotopes section as well which is classified into isotopes and applications. Isotopes considered are carbon (C-13), deuterium (D2), oxygen (O-18), nitrogen (N-15), sulphur (S-32) and others. The stable isotopes have application in diagnostics and therapy, pharmaceutical companies, research section and industrial sector. The leading players of this market are Cambridge Isotope Laboratories (U.S) and Isotec Inc. subsidiary of Sigma Aldrich (U.S.).
The threats for the nuclear medicine/radiopharmaceuticals market include huge capital investment and shortage of qualified technicians. The major problem area of nuclear medicine market is closure of reactors.
Companies Mentioned Include:
- Ablynx Nv
- Abx Gmbh
- Actinium Pharmaceuticals, Inc
- Advanced Accelerator Applications
- Coqui Pharmaceuticals
- Eurisotop
- Fujifilm Corporation
- Isotope Technologies Garching
- Ithemba Labs
- Linde Group
- Ostuka Pharmaceuticals Co Ltd
- Pars Isotope
- Peregrine Pharmaceuticals, Inc
- Perkin Elmer
- Perma-Fix Medical Sa
- Petnet Solution
- Philips Health Care
- Positron Corporation
- Radiomedix, Inc.
- Urenco
- Westinghouse Electric Company
-
Zevacor Molecular
Report Structure:
1 Executive Summary
2 Introduction
3 Market Analysis
4 Radiopharmaceuticals By Type
5 Global Nuclear Medicine Market By End-Users
6 Stable Isotopes
7 Regional Analysis
8 Competitive Landscape
9 Major Player Profiles
For more information visit http://www.researchandmarkets.com/research/t3ptkq/nuclear
